Literature DB >> 34129088

Laparoscopic complete mesocolic excision versus conventional resection for right-sided colon cancer: a propensity score matching analysis of short-term outcomes.

Carmelo Magistro1, Camillo Leonardo Bertoglio1, Alessandro Giani2, Michele Mazzola1, Carolina Rubicondo1, Marianna Maspero1, Pietro Carnevali1, Matteo Origi1, Giovanni Ferrari1.   

Abstract

BACKGROUND: Complete mesocolic excision (CME) for right-sided colon cancer (RCC) is a demanding operation, especially when performed laparoscopically. The potential impact of CME in increasing postoperative complications is still unclear. The aim of our study was to evaluate the safety and feasibility of laparoscopic CME compared with laparoscopic non-complete mesocolic excision (NCME) during colectomy for RCC.
METHODS: Data from a prospectively collected database of patients who underwent laparoscopic right and extended right colectomy at our institution between January 2008 and February 2020 were retrieved and analyzed. Short-term outcomes of patients undergoing CME and NCME were compared. A 1:1 propensity score matching (PSM) was used to balance baseline characteristics between groups.
RESULTS: A total of 663 consecutive patients underwent resection of RCC in the study period. Among these, 500 met the inclusion criteria and after PSM a total of 372 patients were correctly matched, 186 in each group. A similar rate of overall postoperative complications was found between the CME and NCME groups (21.5% and 18.3%, p = 0.436). No difference was found in terms of conversion rate, severe complications, reoperations, readmissions, and mortality. The median number of harvested lymph nodes was higher in the CME group (22 versus 19, p = 0.003), with a lower rate of inadequate sampling (7.0% and 15.1%, p = 0.013).
CONCLUSION: Laparoscopic CME for RCC is technically feasible and safe. It does not seem to be associated with a higher rate of complications or mortality compared with the "traditional" approach, but it allows better nodal sampling.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CME; Cancer; Colectomy; Laparoscopy; Right

Mesh:

Year:  2021        PMID: 34129088     DOI: 10.1007/s00464-021-08601-z

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  6 in total

Review 1.  Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing colonic resection.

Authors:  K C H Fearon; O Ljungqvist; M Von Meyenfeldt; A Revhaug; C H C Dejong; K Lassen; J Nygren; J Hausel; M Soop; J Andersen; H Kehlet
Journal:  Clin Nutr       Date:  2005-04-21       Impact factor: 7.324

Review 2.  Complete mesocolic excision an assessment of feasibility and outcome.

Authors:  Claus Anders Bertelsen
Journal:  Dan Med J       Date:  2017-02       Impact factor: 1.240

3.  Histological inflammatory cell infiltration is associated with the number of lymph nodes retrieved in colorectal cancer.

Authors:  Young Wan Kim; Khalilullah Mia Jan; Duck Hyun Jung; Mee Yon Cho; Nam Kyu Kim
Journal:  Anticancer Res       Date:  2013-11       Impact factor: 2.480

4.  Laparoscopic Colectomy vs Laparoscopic CME: a Retrospective Study of Two Hospitals with Comparable Laparoscopic Experience.

Authors:  Juha Ka Rinne; Anu Ehrlich; Jaana Ward; Ville Väyrynen; Mikael Laine; Ilmo H Kellokumpu; Matti Kairaluoma; Marja K Hyöty; Jyrki Ao Kössi
Journal:  J Gastrointest Surg       Date:  2020-02-05       Impact factor: 3.452

5.  Postoperative morbidity of complete mesocolic excision and central vascular ligation in right colectomy: a retrospective comparative cohort study.

Authors:  Gian Andrea Prevost; Manfred Odermatt; Markus Furrer; Peter Villiger
Journal:  World J Surg Oncol       Date:  2018-10-30       Impact factor: 2.754

  6 in total
  1 in total

1.  Mid-term oncological outcomes after complete versus conventional mesocolic excision for right-sided colon cancer: a propensity score matching analysis.

Authors:  Alessandro Giani; Camillo Leonardo Bertoglio; Michele Mazzola; Irene Giusti; Pietro Achilli; Pietro Carnevali; Matteo Origi; Carmelo Magistro; Giovanni Ferrari
Journal:  Surg Endosc       Date:  2022-01-13       Impact factor: 3.453

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.